(MENAFN- PR Newswire)
GRAMMY® and Golden Globe® Award-nominated artist's cannabis brand to launch in Florida exclusively at Trulieve this summer; partnership will extend to other markets in 2022
TALLAHASSEE, Fla., Feb. 22, 2022 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ('Trulieve' or 'the Company'), a leading and top-performing cannabis company in the United States, today announced an exclusive partnership with multi-platinum-selling, GRAMMY® Award and Golden Globe® Award-nominated recording artist Wiz Khalifa's brand, Khalifa Kush. Through the agreement, Trulieve becomes the exclusive producer, processor and retailer of Khalifa Kush branded products in Florida and other northeast markets, beginning this summer.
'We're excited to partner with the undisputed leader in the Florida market,' said Wiz Khalifa. 'Trulieve's dedication to working with the community and creating an amazing customer experience perfectly lines up with our brand values, making them a great fit for our first expansion to the East Coast.'
Valda Coryat, Chief Marketing Officer of Trulieve, said, 'Trulieve is committed to delivering a broad selection of the highest-quality cannabis brands to better serve our patient communities. Khalifa Kush is a respected brand known for top-tier genetics among cannabis connoisseurs. We look forward to becoming the exclusive home of the brand's premium products in Florida and eventually in other markets.'
As the leading medical cannabis provider in Florida, the second largest medical cannabis market in the U.S., Trulieve offers the largest selection of THC and CBD products in a variety of delivery methods, including edibles, smokable flower, concentrates, tinctures, topical creams, vaporizers, and more. Trulieve also offers statewide home delivery, convenient online ordering, and in-store pickup.
For more information, please visit khalifakush.com and .
About Khalifa Kush Khalifa Kush products were first commercialized in the U.S. in 2015 by global icon Wiz Khalifa. The company has achieved continued growth and success by focusing on high quality and highly sought-after products in legalized cannabis markets. The Khalifa Kush brand offers a growing lineup of flower, pre-rolls, vapes, edibles, and concentrates, powered by proprietary genetics. Khalifa Kush is available in select markets including California, Nevada, Arizona and Utah. Learn more about our upcoming launches in Pennsylvania, Florida and Michigan and shop apparel at KHALIFAKUSH.COM .
About Trulieve Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S. operating in 11 states, with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com .
Facebook: @Trulieve Instagram: @Trulieve Twitter: @Trulieve
Investor Contact Christine Hersey, Director of Investor Relations+1 (424) 202-0210[email protected]
Media Contact Rob Kremer, Executive Director of Corporate Communications+1 (404) 218-3077[email protected]
Khalifa Kush / Wiz Khalifa Contact Dvora Englefield [email protected] Courtni Asbury [email protected] Chris Iacullo [email protected]
MATTIO Communications[email protected]
SOURCE Trulieve Cannabis Corp.
MENAFN22022022003732001241ID1103742233
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.